Community News

Commercialization plan for a synthetic biology “biofoundry” platform

June 25, 2022

You will be working with a seed-stage biotechnology company planning to commercialize a platform for automating common laboratory protocols.

Read More

Prioritization of indications for a novel autoimmune disease therapeutic

May 31, 2022

Project timeline: June 20th – August 2022, 6-8 weeks Who you are: A graduate or professional student (i.e. PhD, MD, PharmD, MBA, MS), postdoc, clinical resident, or recent graduate Enthusiastic about gaining life-science business experience and helping a client identify how to have the most patient-health impact with their therapeutic Eager to build teamwork and […]

Read More

Biotech venture capital due diligence project

May 24, 2022

The Venture Advisors group at BCBA is seeking exceptional candidates to join our current teams. Work with other top tier multi-institutional colleagues to conduct due diligence on life science & healthcare startups for venture capital clients.

Read More

Product launch strategy for a spatial omics platform

March 7, 2022

The client specializes in high-resolution detection of small target gene panels. Recently, the client acquired a complementary technology to offer high-throughput detection of genes with their platform.

Read More

Market analysis and adoption strategy for an in vitro fertilization (IVF) technology

February 15, 2022

You will be working with an early-stage startup founded by Caltech scientists, whose long-term vision is to become the standard of care for IVF. The founders’ mission is to improve the embryo selection process through a new embryo evaluation technology and to eventually enable embryo-rescuing interventions through early detection of poor outcomes. You and the BCBA team will help set the company’s directions by helping them craft their business plan and prepare to raise their Series A funding.

Read More

Strategize the adoption of a novel in vivo screening platform by pharmaceutical companies

February 1, 2022

Who we are: BCBA connects academic science trainees and recent graduates to the Bay Area’s biotech industry through hands-on consulting and due diligence projects. We are a volunteer organization composed of PhD students, post-docs, medical trainees, and young professionals looking to gain professional development skills for jobs in biotech companies, consulting, and venture capital. Over […]

Read More

Market opportunity assessment for a novel electroporation technology

January 26, 2022

Who we are: BCBA connects academic science trainees and recent graduates to the Bay Area’s biotech industry through hands-on consulting and due diligence projects. We are a volunteer organization composed of PhD students, post-docs, medical trainees, and young professionals looking to gain professional development skills for jobs in biotech companies, consulting, and venture capital. Over […]

Read More

Due diligence to guide venture capital investment

December 8, 2021

The multi-institutional project team will perform due diligence on life science and therapeutics startups under consideration by venture capital firms in the Bay Area. For each company, the team may evaluate the following key areas: 1) company capabilities (e.g. scientific merit, intellectual property, etc.), 2) market attractiveness, and 3) competitive landscape. Team members will interact […]

Read More

Indication prioritization for a therapeutics company targeting aging diseases

December 8, 2021

As advances in medicine and technology have enabled societies to enjoy longer lifespans, increasing numbers of people will live to experience the negative effects age-associated diseases. An early-stage therapeutics company has engaged BCBA to identify appropriate molecular targets to combat age-associated diseases using high-throughput, high-dimensional approaches. Specifically, the BCBA team will use primary and secondary […]

Read More

Market opportunity assessment for a molecular structure determination platform company

October 21, 2021

An early-stage contract research organization (CRO) is providing high-throughput molecular structure determination services using a cutting-edge platform, enabling them to determine structures cheaper and more quickly than many competitors. The company believes that these advantages will enable them to capture a significant proportion of the molecular structure determination market, and that a large market opportunity […]

Read More